Exploiting drug-resistant enzymes as tools to identify thienopyrimidinone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H
…, JW Rausch, JA Wilson, H Taskent-Sezgin…
Index: Masaoka, Takashi; Chung, Suhman; Caboni, Pierluigi; Rausch, Jason W.; Wilson, Jennifer A.; Taskent-Sezgin, Humeyra; Beutler, John A.; Tocco, Graziella; Le Grice, Stuart F. J. Journal of Medicinal Chemistry, 2013 , vol. 56, # 13 p. 5436 - 5445
Full Text: HTML
Citation Number: 17
Abstract
The thienopyrimidinone 5, 6-dimethyl-2-(4-nitrophenyl) thieno [2, 3-d] pyrimidin-4 (3 H)-one (DNTP) occupies the interface between the p66 ribonuclease H (RNase H) domain and p51 thumb of human immunodeficiency virus reverse transcriptase (HIV RT), thereby inducing a conformational change incompatible with catalysis. Here, we combined biochemical characterization of 39 DNTP derivatives with antiviral testing of selected compounds. In ...
Related Articles:
[Nallangi, Radhika; Samala, Ganesh; Sridevi, Jonnalagadda Padma; Yogeeswari, Perumal; Sriram, Dharmarajan European Journal of Medicinal Chemistry, 2014 , vol. 76, p. 110 - 117]
[Aurelio, Luigi; Christopoulos, Arthur; Flynn, Bernard L.; Scammells, Peter J.; Sexton, Patrick M.; Valant, Celine Bioorganic and Medicinal Chemistry Letters, 2011 , vol. 21, # 12 p. 3704 - 3707]
[Kassab, Asmaa E.; Gedawy, Ehab M. European Journal of Medicinal Chemistry, 2013 , vol. 63, p. 224 - 230]